Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian Markets Extend Losses
Mon, 9 Mar 01:30 pm

BSE-Sensex and NSE-Nifty extended losses as Sensex fell over 350 points and Nifty fell over a 100 points. S&P BSE Midcap and S&P BSE Smallcap are also trading in the red. Midcap stocks fell around 0.6% while the smallcap stocks fell 0.3%. Crude oil prices per barrel fell down about 0.45% and is currently trading at Rs 3,125. Gold prices per 10 grams is trading higher by Rs 60 at Rs 26,072 while Silver prices per kilogram increased marginally by Rs 26 and is trading at Rs 35,998. The Indian Rupee is trading with gains of 0.70% at Rs 62.58 against the U.S. Dollar.

Majority of the Asian markets finished trading in the red on investor concerns over economic growth, Greece crisis and U.S. increasing interest rates earlier than expected.

Only pharmaceutical stocks are trading marginally in the green despite the markets extending losses. Natco Pharma, Lupin and Sun Pharma are the top gainers within the sector. Natco Pharma gained more than 3% after it launched the first version of sofosbuvir under HEPCINAT brand in Nepal. A bottle of this medicine, which has 28 tablets, is sold for Rs 19,900. Sofosbuvir is used to medicate the hepatitis C infection. On the international platform, this medicine is sold by Gilead Sciences. The company hopes to sell these in the Indian markets, subject to approval from Drugs Controller General of India (DCGI).

The second phase of coal auction gained a lot of traction as a large number of bids were witnessed in this round of auction. Jindal Steel stood the biggest beneficiary of the coal block auction as it bagged Tara coal block of the Chhattisgarh region at an attractive price of Rs 126 per tonne. The shares of Jindal Steel spiked more than 8% today on such development. The Tara coal block has a reserve of about 167 million tonnes of coal. Apart from Jindal Steel; Ambuja Cements and Hindalco also won coal blocks, but with relatively expensive bids.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian Markets Extend Losses". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.